JP Morgan Chase
ANRO icon

JP Morgan Chase’s Alto Neuroscience ANRO Stock Holding History

JP Morgan Chase’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306K Buy
10,904
+10,858
+23,604% +$251K ﹤0.01% 5385
2026
Q1 		$919 Sell
46
-100
-68% -$1.85K ﹤0.01% 7133
2025
Q4 		$2.6K Buy
+146
New +$1.84K ﹤0.01% 6903
2025
Q2 		– Sell
-10,949
Closed -$23.6K – 7729
2025
Q1 		$23.6K Buy
10,949
+708
+7% +$2.53K ﹤0.01% 6105
2024
Q4 		$43.3K Sell
10,241
-14,074
-58% -$87.8K ﹤0.01% 6066
2024
Q3 		$278K Buy
24,315
+20,536
+543% +$251K ﹤0.01% 5246
2024
Q2 		$40.4K Sell
3,779
-21,218
-85% -$276K ﹤0.01% 5940
2024
Q1 		$384K Buy
+24,997
New +$391K ﹤0.01% 4967

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

JP Morgan Chase's ANRO Position: Q2 2026 in Review

JP Morgan Chase increased its Alto Neuroscience (ANRO) stake by 23,604% in Q2 2026, buying an estimated $251K and bringing the position to 10,904 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #5385.

JP Morgan Chase first reported a position in ANRO in Q1 2024 and has held it in 8 quarters since. The position peaked at $384K in Q1 2024. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • JP Morgan Chase held 10,904 shares of Alto Neuroscience worth $306K as of Q2 2026.
  • JP Morgan Chase bought 10,858 Alto Neuroscience shares in Q2 2026, an estimated $251K.
  • Alto Neuroscience made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5385 holding.
  • JP Morgan Chase first reported a position in Alto Neuroscience in Q1 2024 and has held it in 8 quarters since.
  • JP Morgan Chase's Alto Neuroscience position peaked at $384K in Q1 2024.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.